R01 NS035228/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2003	1
2006	1
2008	1
2014	1
2021	0

Page 1

From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology.

Viapiano MS, Matthews RT. Viapiano MS, et al. Trends Mol Med. 2006 Oct;12(10):488-96. doi: 10.1016/j.molmed.2006.08.007. Epub 2006 Sep 7. Trends Mol Med. 2006. PMID: 16962376 Review.

Brevican knockdown reduces late-stage glioma tumor aggressiveness.

Dwyer CA, Bi WL, Viapiano MS, Matthews RT. Dwyer CA, et al. J Neurooncol. 2014 Oct;120(1):63-72. doi: 10.1007/s11060-014-1541-z. Epub 2014 Jul 23. J Neurooncol. 2014. PMID: 25052349 Free PMC article.

BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.

Viapiano MS, Hockfield S, Matthews RT. Viapiano MS, et al. J Neurooncol. 2008 Jul;88(3):261-72. doi: 10.1007/s11060-008-9575-8. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398576 Free PMC article.

A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma.

Viapiano MS, Matthews RT, Hockfield S. Viapiano MS, et al. J Biol Chem. 2003 Aug 29;278(35):33239-47. doi: 10.1074/jbc.M303480200. Epub 2003 Jun 10. J Biol Chem. 2003. PMID: 12799382 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results